← SynDRA
ZALCITABINE
SynDRA canonical compound SYN0002222 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Mechanism of action | nucleoside reverse transcriptase inhibitor |
|---|
| Indication | human immunodeficiency virus (HIV-1) |
|---|
| Disease area | infectious disease |
|---|
All known targets
Mechanisms of action (all sources)
- nucleoside reverse transcriptase inhibitor
- Inhibitor
- pol INHIBITOR
Drug classes
- Anti-HIV Agents
- Anti-Infective Agents
- Anti-Retroviral Agents
- Antimetabolites
- Antiviral Agents
- Enzyme Inhibitors
- Noxae
- Nucleic Acid Synthesis Inhibitors
- Reverse Transcriptase Inhibitors
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- Ro 24-2027/000
- hivid
- dideoxycytidine
- Zalcitabina
- Ddc (ddc)
- Dideoxycytidine
- Zalcitabine (dideoxycytidine,ddc)
- NSC-606170
- RO-24-2027/000
- RO-24-2027000
- RO-242027000
- Ro-24-2027-000
- Hivid
- 2',3'-DIDEOXYCYTIDINE
- ddCyd
- HIVID
- ddC
- Cytidine, 2',3'-dideoxy-
- Zalcitibine
- 4-Amino-1-((2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
- 2,3-dideoxycytidine
- NSC 606170
- UNII-6L3XT8CB3I
- CCRIS 692
- HSDB 7156
- C9H13N3O3
- CHEMBL853
- BRN 0654956
- 6L3XT8CB3I
- CHEBI:10101
- 1-(2,3-Dideoxy-beta-D-ribofuranosyl)cytosine
- WREGKURFCTUGRC-POYBYMJQSA-N
- 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one
- MFCD00012188
- D 5782
- DDC (DDC)
- DdC & Interferon alpha
- DdC & sCD4
Look up ZALCITABINE in the interactive SynDRA portal →